The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Search for "Biologics"

Search results for: Biologics

Tips for Educating Patients in the Age of Biologics

December 15, 2015 • By Monica Richey, MSN, ANP-BC, GNP, BSN

Patient education has always been at the core of the nursing profession. Nurses pride themselves on being great teachers and patient advocates. When self-injectable biologics were first introduced to the market, one of the main goals was to make patients independent and put them in the driver’s seat of their own care. Yet without a… [Read More]

Filed Under: From the College, Patient Perspective, Practice Management Tagged With: Biologics, patient care, patient education, self-injection

EULAR 2015: RA Research Shows Imperfect Guidelines, Suggests Strategies with Biologics

August 17, 2015 • By Thomas R. Collins

ROME, Italy—Even with classification criteria that have been updated and refined over time, rheumatoid arthritis is still a diagnosis that ultimately has to be made with clinical judgment, said Ronald van Vollenhoven, MD, PhD, professor of medicine and chief of clinical therapy research in inflammatory diseases at the Karolinska University in Sweden. His remarks came… [Read More]

Filed Under: Conditions, Meeting Reports, Rheumatoid Arthritis Tagged With: Clinical, Diagnosis, EULAR, patient care, Practice Management, Research, Rheumatoid arthritis

Rising Costs of Biologics in the U.S. Suggest Need for Negotiation Ability

May 21, 2015 • By Rob Goodier (Reuters Health)

The costs of some disease-modifying therapies outpace prescription drug inflation, saddling insured patients with thousands of dollars in out-of-pocket payments and delayed or denied coverage, two new studies have shown. Disease-modifying therapies for multiple sclerosis are rising in cost five to seven times faster than inflation and cost more in the United States than in… [Read More]

Filed Under: Biologics & Biosimilars, DMARDs & Immunosuppressives, Drug Updates Tagged With: Biologics, cost, Drugs, Medicare, Multiple Sclerosis, Research, Rheumatoid arthritis

Vaccines and Biologics: What Rheumatologists Need to Know

December 1, 2014 • By Kurt Ullman

How vaccines, medications and rheumatic disease-related effects on immune system interact... [Read More]

Filed Under: Biologics & Biosimilars, Drug Updates Tagged With: Biologics, Immune System, interaction, Research, Rheumatic Disease, rheumatologist, rheumatology, rituximab, Ullman, vaccines

EULAR 2014: Non-Tumor Necrosis Factor Biologics Update

August 1, 2014 • By Thomas R. Collins

Clinical trials on rheumatology drugs, including sarilumab, show promise for patients with rheumatoid arthritis also taking methotrexate... [Read More]

Filed Under: Biologics & Biosimilars, Conditions, Drug Updates, Rheumatoid Arthritis Tagged With: Biologics, Collins, EULAR, itolizumab, Methotrexate, Rheumatoid arthritis, rheumatologist, rheumatology, rituximab, sarilumab

The American College of Rheumatology Helps Keep Three Biologics Off the SAD List

November 19, 2013 • By Richard Quinn

In October, the Centers for Medicare and Medicaid Services directed carriers to again include three biologics in Medicare Part B coverage.  (posted Nov. 19)... [Read More]

Filed Under: Practice Management Tagged With: Biologics, Medicare, Medicare Part B, SAD List

Meet the Model Biologics Policy

July 1, 2010 • By From the College

At its February meeting, the ACR board of directors approved the Model Biologics Policy, which will be used when discussing guidelines and patients’ quality of treatment with health insurance companies.... [Read More]

Filed Under: From the College, Practice Management, Quality Assurance/Improvement Tagged With: Biologics, Guidelines, Health Insurance, policy, Practice Page

Integrating Immunology and Biologics into Clinical Practice

May 1, 2010 • By From the College

With the rapid expansion of new classes of medications, clinical practice has changed dramatically, and rheumatology health professionals must have a fundamental knowledge of immunology and the mechanisms of action of the biologic agents that have emerged with this expansion. Familiarity with the predrug screening recommended for biologic agents and the appropriate safety and disease monitoring necessary when a person uses these products is essential for the best patient outcomes. Additionally, being able to obtain drug plan authorization for use of biologics and being able to educate patients and their families or support team members about the financial considerations of these drugs helps to ensure best rheumatology practice.... [Read More]

Filed Under: Career Development, Education & Training, From the College, Meeting Reports, Professional Topics Tagged With: Annual Meeting, Biologics, Clinical Practice, Immunology

Managing Office Infusions: From Biologics to Bones

May 1, 2009 • By Staff

On June 9, Josh Brinks, BSN, MSN, FNP, will address the management of office infusions during the ARHP June audioconference/webcast.... [Read More]

Filed Under: From the College Tagged With: ARHP News, Clinical, Education

Modern Treatment Tied to Low Disease Activity in Pregnant RA Patients

February 24, 2021 • By Lisa Rapaport

(Reuters Health)—Many pregnant women with rheumatoid arthritis (RA) may achieve low disease activity in the third trimester with a modern treatment regimen that includes anti-tumor necrosis factor (TNF) medications, a recent study suggests. Researchers examined data on 309 patients with RA who were pregnant or trying to conceive and who were treated with modern treat-to-target… [Read More]

Filed Under: Conditions, Rheumatoid Arthritis Tagged With: Anti-TNF, anti-TNF agent, pregnancy, pregnant women, Rheumatoid Arthritis (RA), Women

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 57
  • Next Page »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

This site uses cookies: Find out more.